FTSE battles with drugs

clock

The FTSE 100 Index fell 23 points, or 0.4%, to 6,208 points today, led by drug companies GlaxoSmithKline and AstraZeneca.

GlaxoSmithKline declined 1.88% to £13.60 and AstraZeneca fell 2.11% to £30.10 on fears the US Congress will cut the price of drugs following Democrats triumph in the recent mid-term elections. The miners presented a mixed picture, as BHP Billiton fell 2.59% to £10.16 and Xstrata dropped 2.51% to £22.95, while Lonmin jumped 3.04% to £31.83 on the back of bid rumours. Anglo American rose 1.22% to £24.96 after the Oppenheimer family sold a third of its stake in the world's second-biggest miner to China Vision Resources. The transaction is worth around £419m. In the US, the Dow Jones i...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Decoding the conflicting investment advice of Warren Buffett

Decoding the conflicting investment advice of Warren Buffett

'He leaves us with a wealth of opinion and information about markets and investing'

Laith Khalaf
clock 09 December 2025 • 5 min read
Private assets in wealth management: The time for talking is over

Private assets in wealth management: The time for talking is over

'The first barrier to adoption is accessibility through existing infrastructure'

Russell Andrews
clock 08 December 2025 • 4 min read
China: Beyond trade tensions and tariffs

China: Beyond trade tensions and tariffs

'So what do you think about China?'

Gabriel Sacks
clock 05 December 2025 • 4 min read